| |
|
|
|
Inmune Bio Inc  
|
|
18.78 -1.78 (-0.09%) |
01-27 16:00 |
|
Open: |
19.51 |
Pre close: |
20.56 |
Target:
|
26.03 
|
|
High: |
19.78 |
Low: |
18.4978 |
Resistance:
|
22.29
29.99
|
|
Volume: |
430,376 |
Market Cap: |
253M |
Support:
|
9.82
8.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
20.18
|
MACD |
MACD(12,26):
|
2.18 |
|
MA(20): |
20.52  |
Signal(12,26,9): |
2.89 |
|
MA(100): |
11.63 |
Stochastic Oscillator |
%K(14,3):
|
24.76 |
|
MA(250): |
8.42 |
%D(3): |
30.99 |
|
Average Volume(K) |
3-Month: |
25532
|
52-Week |
High:
|
29.99 |
|
10-Days: |
65965 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
50.78 |
Change(%): |
292.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.990 |
Return on Equity (ttm) |
-34.0 |
Shares Out. (M) |
13.45 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-20.8 |
Shares Float (M) |
6.69 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
45.07 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
12.61 |
|
Forward EPS |
-0.750 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
487 |
|
Book Value (p.s.) |
3.060 |
EBITDA (p.s.) |
0.000 |
P/E |
-18.97 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.14 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.98 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.08 |
P/CF |
-36.19 |
|
|
|
|
|
|
